Health (Assisted Human Reproduction) Act 2024
|
SCHEDULE 5 Types of conditions that ahrra may attach to licence authorising provision of ahr treatment or that are deemed to be attached to such licence | ||
|
PART 1 Types of Conditions that AHRRA may Attach to Licence | ||
1. A condition requiring the holder of a licence to give notice in writing to the AHRRA of any change of circumstances that a reasonable person would consider might be a change in circumstances— | ||
(a) that will or may adversely affect, in a material way, the provision of the AHR treatment authorised by the licence, or | ||
(b) that, if the holder did not hold that licence and were to make a licence application for a licence in the like terms, the provisions of Part 10 , as in force at the time that the licence was granted, would prevent the AHRRA from granting a licence in such terms to the holder. | ||
2. Any type of condition specified, for the purposes of this paragraph, in regulations made under section 156 (3). | ||
|
PART 2 Conditions Deemed to be Attached to Licence | ||
1. A condition that the holder of a licence continues to be a fit and proper person to hold the licence. | ||
2. (a) A condition that the AHR treatment provider shall not place a relevant gamete or embryo into the body of a woman in an attempt to achieve a pregnancy. | ||
(b) In this paragraph— | ||
“enucleated egg or embryo” means an egg or embryo from which the nuclear DNA has been removed; | ||
“genome” means an organism’s complete set of DNA, including all of its genes; | ||
“mitochondrial donation” and “mitochondria replacement” mean the removal of any nuclear DNA from an egg or embryo that has abnormal mitochondria and the insertion of this nuclear DNA into another enucleated egg or embryo that has healthy mitochondria; | ||
“relevant gamete or embryo” means a human gamete or embryo— | ||
(i) the genome of which has been modified such that the modification could be inherited by children born from the gamete or embryo or the descendants of such children, or | ||
(ii) which has undergone mitochondrial donation or mitochondrial replacement. | ||
3. A condition specified for the purposes of this paragraph in regulations made under section 156 (3). |